KD Logo

Coya Therapeutics Inc (COYA) rating initates by D. Boral Capital

Coya Therapeutics Inc’s filing revealed that its Chief Financial Officer SNYDER DAVID S acquired Company’s shares for reported $12934.0 on Nov 14 ’24. In the deal valued at $7.19 per share,1,800 shares were bought. As a result of this transaction, SNYDER DAVID S now holds 8,800 shares worth roughly $47344.0.

Then, Swaminathan Arun bought 5,000 shares, generating $36,797 in total proceeds. Upon buying the shares at $7.36, the Chief Executive Officer now owns 10,000 shares.

Before that, Grossman Fred bought 2,710 shares. Coya Therapeutics Inc shares valued at $19,973 were divested by the Chief Medical Officer at a price of $7.37 per share. As a result of the transaction, Grossman Fred now holds 2,710 shares, worth roughly $14579.8.

D. Boral Capital initiated its Coya Therapeutics Inc [COYA] rating to a Buy in a research note published on December 04, 2024; the price target was $15.

Price Performance Review of COYA

On Friday, Coya Therapeutics Inc [NASDAQ:COYA] saw its stock fall -3.93% to $5.38. Over the last five days, the stock has lost -6.76%. Coya Therapeutics Inc shares have fallen nearly -6.11% since the year began. Nevertheless, the stocks have fallen -8.50% over the past one year. While a 52-week high of $10.69 was reached on 01/06/25, a 52-week low of $4.75 was recorded on 01/17/25. SMA at 50 days reached $6.11, while 200 days put it at $6.95.

Levels Of Support And Resistance For COYA Stock

The 24-hour chart illustrates a support level at 5.24, which if violated will result in even more drops to 5.09. On the upside, there is a resistance level at 5.61. A further resistance level may holdings at 5.84. The Relative Strength Index (RSI) on the 14-day chart is 38.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.87%. Stochastics %K at 15.88% indicates the stock is a buying.

How much short interest is there in Coya Therapeutics Inc?

A steep rise in short interest was recorded in Coya Therapeutics Inc stocks on 2024-12-31, growing by 21593.0 shares to a total of 0.21 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 0.19 million shares. There was a rise of 10.32%, which implies that there is a positive sentiment for the stock.

Most Popular